Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia
Clinical trial NCT05278156 · COMPLETED
Trial details
- NCT number
- NCT05278156
- Sponsor
- Celon Pharma SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-19
- Primary completion
- 2024-06-05
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.